Repligen Corp (NAS:RGEN)
$ 171.78 -0.16 (-0.09%) Market Cap: 9.60 Bil Enterprise Value: 9.56 Bil PE Ratio: 687.12 PB Ratio: 4.87 GF Score: 94/100

Repligen Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2020 / 08:00PM GMT
Release Date Price: $127.15 (-4.66%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Good afternoon. Welcome, everybody, to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard, I cover the life science tools in diagnostics sector here at the firm. Very happy to have Repligen with us back at the conference this year. Joining us for our conversation this afternoon, Mr. Tony Hunt, CEO; as well as Jon Snodgres, CFO. Thank you both for being here. I will say to anyone in the audience who's listening in, please feel free to e-mail me if you have any questions, and I'll do my best and let's try to work those in.

Questions & Answers

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

So maybe let's -- if we can just jump right into it, Tony, if think about the bioprocessing industry at a high level, about a $10 billion market, growing sort of high single digits. You've been growing double that rate organically for quite some time, did 33% last year. What are some of the key factors to think about in terms of your ability

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot